| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 7 | |
| #2 | Canada | 5 | |
| #3 | Israel | 5 | |
| #4 | New Zealand | 4 | |
| #5 | China | 3 | |
| #6 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Foods and drinks | |
| #3 | Biotechnology | |
| #4 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Foods | |
| #4 | Peptides | |
| #5 | Fodder | |
| #6 | Special foods | |
| #7 | Analysing materials | |
| #8 | Measuring microorganism processes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Hansson Hans-Arne | 15 |
| #2 | Lange Stefan | 14 |
| #3 | Jennische Eva | 8 |
| #4 | Bergstrom Tomas | 2 |
| #5 | Lonnroth Ivar | 2 |
| #6 | Eriksson Peter | 1 |
| #7 | Persson Anders | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CN109563142A | Antisecretory factor 17 | |
| US2016030515A1 | Use of antisecretory factors (AF) for optimizing cellular uptake | |
| AU2015265852A1 | Antisecretory factor complex assay | |
| CA3036216A1 | Use of antisecretory factor (af) in glioblastoma treatment | |
| AU2012201165A1 | New approach to treat intraocular hypertension | |
| NZ572256A | Medical uses of antisecretory proteins for the treatment or prevention of dysfunction of lipid rafts, receptors and/or caveolae |